Notice: This company has been marked as potentially delisted and may not be actively trading. Impel Pharmaceuticals (IMPL) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Impel-Stelda Enters Primary Packaging Business of Tube FillingOctober 12, 2024 | msn.comImexpharm achieves net revenue of US$39.74 million in 2024H1July 26, 2024 | msn.comCompliant Marketing In The Pharmaceutical Industry's Regulatory MazeMay 17, 2024 | forbes.comImpel Pharmaceuticals Inc. (IMPLQ)March 13, 2024 | finance.yahoo.comImpel Pharma Mulls Sale, Signs Stalking Horse Deal; Files For Chapter 11 ProtectionDecember 20, 2023 | markets.businessinsider.comImpel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate SaleDecember 20, 2023 | finance.yahoo.comAdrian Adams steps down as CEO of Seattle's Impel PharmaceuticalsNovember 6, 2023 | bizjournals.comAnalysts Offer Insights on Healthcare Companies: Impel Pharmaceuticals (IMPL) and Relay Therapeutics (RLAY)October 9, 2023 | markets.businessinsider.comImpel Pharmaceuticals Announces Exploration of Strategic AlternativesOctober 5, 2023 | finance.yahoo.comImpel Pharmaceuticals (IMPL) Receives a Hold from JonesTradingSeptember 14, 2023 | markets.businessinsider.comTrading was temporarily halted for "IMPL" at 10:09 AM with a stated reason of "LULD pause."September 13, 2023 | marketbeat.comTrading was temporarily halted for "IMPL" at 10:09 AM with a stated reason of "LULD pause."September 13, 2023 | marketbeat.comWhy Is Impel Pharmaceuticals (IMPL) Stock Up 32% Today?September 8, 2023 | msn.comJonesTrading Reaffirms Their Hold Rating on Impel Pharmaceuticals (IMPL)August 22, 2023 | markets.businessinsider.comImpel Pharma Shares Tumble 46% After Breaching Terms of Credit AgreementAugust 16, 2023 | marketwatch.comImpel Pharma (NASDAQ:IMPL) Plummets on Viability ConcernsAugust 16, 2023 | msn.comWhy Is Impel Pharmaceuticals (IMPL) Stock Down 35% Today?August 16, 2023 | investorplace.comBiotech Catches Major Premarket BidJuly 5, 2023 | theglobeandmail.com84P.SG - Impel Pharmaceuticals IncJuly 3, 2023 | finance.yahoo.comDirector at Impel Pharmaceuticals Acquires Company Stock Options Worth 13,222 SharesJune 21, 2023 | benzinga.comImpel Pharmaceuticals Board Member Awarded $15K Worth of Stock OptionsJune 21, 2023 | benzinga.comImpel Pharmaceuticals Director Awarded $15K Worth of Stock OptionsJune 21, 2023 | benzinga.comImpel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache SocietyJune 15, 2023 | finance.yahoo.comTrading was temporarily halted for "IMPL" at 09:05 AM with a stated reason of "LULD pause."May 17, 2023 | marketbeat.comImpel Pharmaceuticals Inc. (IMPL)May 17, 2023 | uk.finance.yahoo.comImpel Pharmaceuticals First Quarter 2023 Earnings: Misses ExpectationsMay 13, 2023 | finance.yahoo.comRecap: Impel Pharmaceuticals Q1 EarningsMay 12, 2023 | msn.comImpel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business UpdateMay 12, 2023 | finance.yahoo.comEarnings Outlook For Impel PharmaceuticalsMay 11, 2023 | msn.comImpel Pharmaceuticals gets new CFOMay 10, 2023 | msn.comImpel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial OfficerMay 10, 2023 | finance.yahoo.comInvestors in Impel Pharmaceuticals (NASDAQ:IMPL) from a year ago are still down 67%, even after 26% gain this past weekMay 5, 2023 | finance.yahoo.comImpel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023May 5, 2023 | finance.yahoo.comImpel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine MedicationsApril 26, 2023 | finance.yahoo.comImpel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual MeetingApril 11, 2023 | finance.yahoo.comImpel Pharmaceuticals Inc. (NASDAQ:IMPL) Full-Year Results: Here's What Analysts Are Forecasting For This YearMarch 30, 2023 | finance.yahoo.comImpel Pharmaceuticals Inc. (NASDAQ:IMPL) Q4 2022 Earnings Call TranscriptMarch 27, 2023 | finance.yahoo.comImpel Pharmaceuticals Inc. (NASDAQ:IMPL) Analysts Just Slashed This Year's Revenue Estimates By 12%March 26, 2023 | finance.yahoo.comImpel Pharmaceuticals Inc. (IMPL) Reports Q4 Loss, Tops Revenue EstimatesMarch 24, 2023 | msn.comImpel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateMarch 24, 2023 | finance.yahoo.comImpel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023March 17, 2023 | finance.yahoo.comImpel Pharmaceuticals to Participate in Upcoming Investor Conferences in MarchMarch 3, 2023 | finance.yahoo.comImpel Pharma says reducing headcount by 16%, eliminating pipeline programsFebruary 24, 2023 | seekingalpha.comWhy Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionFebruary 23, 2023 | msn.comImpel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial OpportunityFebruary 22, 2023 | finance.yahoo.comImpel Pharmaceuticals Announces Strategic Reprioritization, Continues Focus on Maximizing Trudhesa® Commercial OpportunityFebruary 22, 2023 | finance.yahoo.comOcular Therapeutix (OCUL) Moves 35.1% Higher: Will This Strength Last?February 14, 2023 | nasdaq.comImpel Pharmaceuticals Inc. (NASDAQ:IMPL) to Post FY2027 Earnings of $1.16 Per Share, Wedbush ForecastsImpel Pharmaceuticals Inc. (NASDAQ:IMPL - Get Rating) - Research analysts at Wedbush issued their FY2027 earnings estimates for Impel Pharmaceuticals in a research report issued on Monday, January 23rd. Wedbush analyst L. Chico expects that the company will post earnings per share of $1.16 for thJanuary 26, 2023 | marketbeat.comImpel Pharmaceuticals Inc. (IMPL) Q3 2022 Earnings Call TranscriptNovember 14, 2022 | seekingalpha.comImpel Pharmaceuticals Inc. (IMPL) Reports Q3 Loss, Lags Revenue EstimatesNovember 14, 2022 | nasdaq.com Get Impel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMPL and its competitors with MarketBeat's FREE daily newsletter. Email Address Free Ebook shares Tesla’s roadmap to $500 a share (Ad)Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future. To claim your copy, follow this link IMPL Media Mentions By Week IMPL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMPL News Sentiment▼0.000.49▲Average Medical News Sentiment IMPL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMPL Articles This Week▼00▲IMPL Articles Average Week Get Impel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMPL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ATXI News Today APM News Today TCRT News Today ARTL News Today NBY News Today SNPX News Today ONCT News Today LIXT News Today PPBT News Today NCNA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMPL) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Impel Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Impel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
